Myfortic 180mg Tablet

Product Overview

About Myfortic

Myfortic is a medication containing the active ingredient Mycophenolate sodium, classified as Immunosuppressant medication. Mycophenolic acid is an immunosuppressant medication used to prevent rejection following organ transplantation and to treat autoimmune conditions such as Crohn's disease, lupus and myasthenia gravis. Specifically it is used following kidney, heart, and liver transplantation.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE Mycophenolic acid delayed-release tablets are an antimetabolite immunosuppressant indicated for prophylaxis of organ.
• Use only as directed on the product label or by a healthcare professional.
• Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

Mycophenolate sodium, the active ingredient in Myfortic, belongs to the Immunosuppressant medication class. 1 INDICATIONS AND USAGE Mycophenolic acid delayed-release tablets are an antimetabolite immunosuppressant indicated for prophylaxis of organ rejection in adult patients receiving kidney transplants and in pediatric patients at least 5 years of age and older who are at least 6 months post kidney transplant. (1. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Myfortic. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Myfortic for extended periods without medical advice.